Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Cardiology Cases|December 12, 2018
Postpartum spontaneous coronary dissection presenting with ventricular fibrillationDaniel Addison, Jonathan Brammer, Swapna Gupta, et al.
Frontiers in Oncology|April 1, 2022
Cytokines in the Pathogenesis of Large Granular Lymphocytic LeukemiaColleen Isabelle, Amy Boles, Nitin Chakravarti, et al.
Leukemia & Lymphoma|October 12, 2024
Combination ruxolitinib and belumosudil is tolerable and induces responses despite treatment failure as monotherapiesJean Caputo, Ayush Peddireddi, Subodh Bhatta, et al.
Cancer Management and Research|December 8, 2021
Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution ExperienceAndrew Schaefer, Ying Huang, Adam Kittai, et al.
Therapeutic Advances in Hematology|July 28, 2022
Outcomes of patients with diffuse large B-cell and high-grade B-cell lymphomas with synchronous CNS and systemic involvement at diagnosis treated with high-dose methotrexate and R-CHOP: a single-center retrospective studyMegan Fleming, Ying Huang, Emily Dotson, et al.
Blood Advances|November 17, 2021
Feasibility of high-dose methotrexate administered on day 1 of (R)CHOP in aggressive non-Hodgkin lymphomasMegan Fleming, Ying Huang, Emily Dotson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 19, 2020
Fluoroquinolone Prophylaxis in Autologous Stem Cell Transplantation: Worthy of a Second LookJoseph E Maakaron, Christina Liscynesky, Zeinab El Boghdadly, et al.
Discovery Medicine|May 5, 2017
Emerging insights on the pathogenesis and treatment of extranodal NK/T cell lymphomas (ENKTL)Bradley M Haverkos, Carrie Coleman, Alejandro A Gru, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 4, 2026
Clinical characteristics associated with terminal methotrexate clearance in patients with non-Hodgkin lymphomas receiving high-dose methotrexateZachary J Arnold, Jordan Lundberg, Tracy Wiczer, et al.
Cancer Medicine|January 19, 2023
Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agentsMuhammad Salman Faisal, Walter Hanel, Timothy Voorhees, et al.
Pageof 2